“Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials”. SKIN The Journal of Cutaneous Medicine 8, no. 4 (July 23, 2024): s406. Accessed May 13, 2026. https://skin.dermsquared.com/skin/article/view/2854.